BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31335439)

  • 1. Meningitis vaccines in children: what have we achieved and where next?
    McAlpine A; Sadarangani M
    Curr Opin Infect Dis; 2019 Oct; 32(5):510-516. PubMed ID: 31335439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implications of vaccines for prevention of bacterial meningitis.
    Riordan A
    Curr Opin Neurol; 2010 Jun; 23(3):319-24. PubMed ID: 20173637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in bacterial conjugate vaccines.
    Goldblatt D
    J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.
    Nigrovic LE; Kuppermann N; Malley R;
    Acad Emerg Med; 2008 Jun; 15(6):522-8. PubMed ID: 18616437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013.
    Mihret W; Lema T; Merid Y; Kassu A; Abebe W; Moges B; Tenna A; Woldegebriel F; Yidnekachew M; Mekonnen W; Ahmed A; Yamuah L; Silamsaw M; Petros B; Oksnes J; Rosenqvist E; Ayele S; Aseffa A; Caugant DA; Norheim G
    Emerg Infect Dis; 2016 Jan; 22(1):75-8. PubMed ID: 26689450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of bacterial meningitis.
    Peltola H
    Infect Dis Clin North Am; 1999 Sep; 13(3):685-710, viii. PubMed ID: 10470562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the best way to use conjugate vaccines?
    Seale A; Finn A
    Curr Opin Infect Dis; 2011 Jun; 24(3):219-24. PubMed ID: 21522065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of CRM₁₉₇ conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants.
    Mallet E; Brachet E; Fernsten P; Laudat F; Razmpour A; Gruber WC;
    Vaccine; 2011 Aug; 29(34):5812-9. PubMed ID: 21296118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.
    Tagbo BN; Bancroft RE; Fajolu I; Abdulkadir MB; Bashir MF; Okunola OP; Isiaka AH; Lawal NM; Edelu BO; Onyejiaka N; Ihuoma CJ; Ndu F; Ozumba UC; Udeinya F; Ogunsola F; Saka AO; Fadeyi A; Aderibigbe SA; Abdulraheem J; Yusuf AG; Sylvanus Ndow P; Ogbogu P; Kanu C; Emina V; Makinwa OJ; Gehre F; Yusuf K; Braka F; Mwenda JM; Ticha JM; Nwodo D; Worwui A; Biey JN; Kwambana-Adams BA; Antonio M
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S81-S88. PubMed ID: 31505626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants.
    Lagos R; Munoz A; Levine MM; Watson W; Chang I; Paradiso P
    Vaccine; 2009 Apr; 27(17):2299-305. PubMed ID: 19428843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial.
    Buttery JP; Riddell A; McVernon J; Chantler T; Lane L; Bowen-Morris J; Diggle L; Morris R; Harnden A; Lockhart S; Pollard AJ; Cartwright K; Moxon ER
    JAMA; 2005 Apr; 293(14):1751-8. PubMed ID: 15827314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conjugate vaccine for the prevention of pediatric pneumococcal disease.
    Murray D; Jackson C
    Mil Med; 2002 Aug; 167(8):671-7. PubMed ID: 12188240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards meningitis prevention in the conjugate vaccines era.
    Laval CA; Pimenta FC; de Andrade JG; Andrade SS; de Andrade AL
    Braz J Infect Dis; 2003 Oct; 7(5):315-24. PubMed ID: 14552741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vaccines on bacterial meningitis worldwide.
    McIntyre PB; O'Brien KL; Greenwood B; van de Beek D
    Lancet; 2012 Nov; 380(9854):1703-11. PubMed ID: 23141619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988-1998.
    Neuman HB; Wald ER
    Clin Pediatr (Phila); 2001 Nov; 40(11):595-600. PubMed ID: 11758958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing meningitis vaccines.
    Buttery JP; Moxon ER
    J R Coll Physicians Lond; 2000; 34(2):163-8. PubMed ID: 10816873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-based vaccines.
    Knaust A; Frosch M
    Int J Med Microbiol; 2004 Oct; 294(5):295-301. PubMed ID: 15532988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against bacterial meningitis.
    Segal S; Pollard AJ
    Br Med Bull; 2004; 72():65-81. PubMed ID: 15802609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.